Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Login

2024
November 7
3:00 pm -
4:30 pm
CET
Webinar
Virtual
Challenges and Obstacles in UPC Pharma Litigation
LES International
Dispute Resolution Committee

The upcoming panel discussion on the first year of the Unified Patent Court (UPC) with a focus on pharmaceutical cases promises to be a highly insightful event. This discussion will bring together UPC judges, in-house counsels and leading litigators to examine the initial impact and implications of the UPC's decisions in the pharmaceutical sector.

The panel will explore key topics such as the strategic considerations of opting patents in or out of the UPC system, parallel national and UPC litigation strategies, the court's approach to complex biotech and pharmaceutical patent cases in preliminary injunction and main proceedings, and the implications of the UPC's decisions for future litigation strategies in the pharma industry.

This event will be an essential opportunity for professionals in LESI as well as in the wider licensing and dispute resolution community to gain insights into how the UPC's first year has influenced the sector and what to expect moving forward.

This panel is especially relevant for those involved in pharmaceutical patent litigation, as it will provide critical analysis and predictions for the future, ensuring that participants are well-equipped to navigate the evolving European patent landscape.

MODERATOR: Marleen van den Horst (Partner, LaGro)

PANEL:

Walter Schober (UPC Judge, Local Division Vienna)

Peter Blok (UPC Judge, Court of Appeal Luxembourg)

Kristin Cooklin (Group Head of IP, Recordati)

James Horgan (Chief IP Counsel, MSD)

Thomas Adocker (Partner, Taylor Wessing)